Dr. Ayesha Kaleem, MD

Dr. Kaleem practices at Nephrology Associates of North Central Florida P A in Gainesville, Florida.

Dr. Kaleem's NPI, 1376618645, was assigned on November 22, 2006. Dr. Kaleem graduated from Aga Khan Medical College in 1992. Dr. Kaleem holds Florida license ME79639.

Dr. Kaleem's primary practice is Nephrology Associates of North Central Florida P A, at 4423 NW 6th Pl, Gainesville, FL 32607 in Alachua County. The practice phone is (352) 377-5600.

Dr. Kaleem's primary practice is Nephrology Associates of North Central Florida P A in Gainesville, Florida. Dr. Kaleem is also affiliated with HCA Florida North Florida Hospital. The medical group on file is SIMEDHealth. Dmand AI also links Dr. Kaleem to 3 more hospitals, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaleem practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kaleem's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kaleem is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Kaleem's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists acute kidney failure, chronic kidney disease and kidney cysts among the conditions Dr. Kaleem treats.

CMS data shows 1,549 Medicare services from Dr. Kaleem across 10 procedure codes in 2024, for 500 Medicare patients. Medicare paid $175,401 for them.

CMS counts 500 Medicare patients who saw Dr. Kaleem in 2024. The largest group is 75 to 84, with 216 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 3.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaleem's median patient age at 74, with 58% women.

In 2024, Dr. Kaleem wrote 944 Medicare Part D claims for 238 patients. 97% of them were for generic drugs. CMS names the drug for 813 of them, across 17 drugs with 11 or more claims each, at $12,609 in total drug cost. In 2023, CMS named 787 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kaleem for performance year 2024, reported individually. Dr. Kaleem accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaleem as offering telehealth.

Dmand AI links 6 papers to Dr. Kaleem, published from 2013 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Dendritic Cells, Flow Cytometry and Kidney Failure, Chronic. Dr. Kaleem's most frequent co-authors are Michael J. Clare-Salzler, MD, Uma Ganapathy Iyer, MD and Philip A. Efron, MD.

CMS Open Payments shows 18 general payments to Dr. Kaleem from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Relypsa, Inc. paid the most, $177.

Dr. Kaleem graduated from Aga Khan Medical College in 1992.

Dr. Kaleem is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.